XML 45 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Fair Value Measurements of Financial Instruments (Tables)
12 Months Ended
Jan. 02, 2021
Fair Value Disclosures [Abstract]  
Fair Value Assets and Liabilities Measured on Recurring and Nonrecurring Basis Table
Financial instruments measured at fair value were as follows (in thousands):
Fair value as of measurement dateQuoted prices in active markets for identical assets
(Level 1)
Significant other observable inputs
(Level 2)
Significant unobservable inputs
(Level 3)
Balance as of January 2, 2021
Cash and cash equivalents (including money market funds) (1)$116,120 $116,120 $— $— 
Government securities (2)$6,371 $— $6,371 $— 
Corporate bonds (2)$7,228 $— $7,228 $— 
Derivative financial instruments - liability (4)$2,328 $— $2,328 $— 
Deferred stock-based compensation (5)$7,207 $— $7,207 $— 
Balance as of December 28, 2019
Cash and cash equivalents (including money market funds) (1)$52,073 $52,073 $— $— 
Government securities (2)$6,339 $— $6,339 $— 
Corporate bonds (2)$6,323 $— $6,323 $— 
Derivative financial instruments - asset (3)$276 $— $276 $— 
Deferred stock-based compensation (5)$7,503 $— $7,503 $— 

The index below indicates the line item in the Consolidated Balance Sheets where the financial instruments are reported:

(1) "Cash and cash equivalents"
(2) Current portion - "Short-term investments"; Long-term portion - "Other Assets"
(3) Current portion - "Prepaid expenses and other current assets"; Long-term portion - "Other Assets"
(4) Current portion - "Accounts payable and accrued expenses"; Long-term portion - "Other Long-Term Liabilities"
(5) Current portion - "Current maturities of other long-term obligations"; Long-term portion - "Other Long-Term Liabilities"